Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection. (Q36088274)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807712 AND SRC:MED&resulttype=core&format=json

10 January 2020

review article

2 references

25 October 2022

Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807712 AND SRC:MED&resulttype=core&format=json

10 January 2020

main subject

anti-retroviral agent

0 references

1 reference

25 October 2022

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807712 AND SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Torre D

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807712 AND SRC:MED&resulttype=core&format=json

10 January 2020

Speranza F

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807712 AND SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 March 2005

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807712 AND SRC:MED&resulttype=core&format=json

10 January 2020

25 October 2022

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807712 AND SRC:MED&resulttype=core&format=json

10 January 2020

25 October 2022

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807712 AND SRC:MED&resulttype=core&format=json

10 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807712 AND SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

66-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807712 AND SRC:MED&resulttype=core&format=json

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Changes in pathological findings at autopsy in AIDS cases for the last 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

21 January 2018

Schizophrenia and HIV.

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Pericardial effusion and pericardiocentesis in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Coronary artery disease and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Renal toxicity of protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Clinical aspects and management of AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Effect of highly active antiretroviral therapy on frequency of oral warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Effect of highly active antiretroviral therapy on the incidence of HIV-related cytomegalovirus retinitis and retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

21 January 2018

2 references

https://api.crossref.org/works/10.1111/J.1468-1293.2005.00268.X

21 January 2018

12 December 2020

Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy

1 reference

12 December 2020

Are we missing an epidemic of HIV-associated nephropathy?

1 reference

12 December 2020

The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection

1 reference

12 December 2020

Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression

1 reference

12 December 2020

The gastrointestinal and hepatic manifestations of the acquired immunodeficiency syndrome

1 reference

12 December 2020

Cardiac complications in acquired immunodeficiency syndrome (AIDS): a review

1 reference

12 December 2020

Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals

1 reference

12 December 2020

HIV-associated renal disease in London hospitals

1 reference

12 December 2020

Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement

1 reference

12 December 2020

Changing morbidity of cutaneous diseases in patients with HIV after the introduction of highly active antiretroviral therapy including a protease inhibitor

1 reference

12 December 2020

Immune deficiency and risk for malignancy among persons with AIDS

1 reference

12 December 2020

AIDS-related malignancies

1 reference

12 December 2020

HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group

1 reference

12 December 2020

Neovascularization of the optic disc after highly active antiretroviral therapy in an AIDS patient with cytomegalovirus retinitis--A new immune recovery-related ocular disorder?

1 reference

12 December 2020

Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy

1 reference

12 December 2020

Diagnosis and treatment of colonic disease in AIDS

1 reference

12 December 2020

Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy

1 reference

12 December 2020

Heart involvement in AIDS: a prospective study during various stages of the disease

1 reference

12 December 2020

Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia

1 reference

12 December 2020

Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia

1 reference

12 December 2020

[Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV]

1 reference

12 December 2020

Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Oral Lesions in HIV/AIDS Patients Undergoing Highly Active Antiretroviral Treatment Including Protease Inhibitors: A New Face of Oral AIDS?

1 reference

12 December 2020

Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients

1 reference

12 December 2020

AIDS-associated membranous nephropathy with advanced renal failure: response to prednisone

1 reference

12 December 2020

HIV and diarrhea in the era of HAART: 1998 New York State hospitalizations

1 reference

12 December 2020

Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy

1 reference

12 December 2020

Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects

1 reference

12 December 2020

Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy

1 reference

12 December 2020

Nephropathy associated with infection by human immunodeficiency virus: a report on 11 cases including 6 treated with zidovudine

1 reference

12 December 2020

Protease inhibitor therapy for HIV infection: the effect on HIV-associated nephrotic syndrome

1 reference

12 December 2020

Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group

1 reference

12 December 2020

Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART.

1 reference

12 December 2020

Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV-infected subjects

1 reference

12 December 2020

Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study.

1 reference

12 December 2020

Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort

1 reference

12 December 2020

1 reference

12 December 2020

Viruses causing diarrhoea in AIDS.

1 reference

12 December 2020

HIV-1-associated nephropathy and response to highly-active antiretroviral therapy

1 reference

12 December 2020

Opportunistic intraocular infections in AIDS

1 reference

12 December 2020

Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy

1 reference

12 December 2020

HIV-1 peripheral neuropathy and combination antiretroviral therapy

1 reference

12 December 2020

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease

1 reference

12 December 2020

Dermatological diseases and signs of HIV infection.

1 reference

12 December 2020

Salmonella, Campylobacter and Shigella in HIV-seropositive patients

1 reference

12 December 2020

Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study

1 reference

12 December 2020

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

1 reference

12 December 2020

The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs

1 reference

12 December 2020

Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects

1 reference

12 December 2020

Predictors of survival in HIV-infected patients on hemodialysis

1 reference

12 December 2020

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

12 December 2020

10.1111/J.1468-1293.2005.00268.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807712 AND SRC:MED&resulttype=core&format=json

10 January 2020

PMC publication ID

7165991

0 references

1 reference